Thomas Moran – Press/Media — Icahn School of Medicine at Mount Sinai

View Scopus Profile

Emailthomas.moranmssmedu

h-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

1 - 25 out of 40 results
- Title
- Date(ascending)

EUA in Hand, MicroGEM Aims to Grow Market for 30-minute RT-PCR System
Thomas Moran
17/06/22
2 items of Media coverage
Press/Media
US Patent Issued to ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI on Nov. 30 for "Broadly neutralizing anti-human cytomegalovirus (HCMV) antibodies and methods of use thereof" (New York Inventors)
Thomas Moran & Domenico Tortorella
1/12/21
1 item of Media coverage
Press/Media
Icahn School of Medicine at Mount Sinai Gets Patent for Broadly Neutralizing Anti-Human Cytomegalovirus (HCMV) Antibodies and Methods of Use Thereof
Thomas Moran
1/12/21
1 item of Media coverage
Press/Media
COVID-19 test maker MicroGEM will create 100s of jobs at new Ogden plant
Thomas Moran
8/02/21
1 item of Media coverage
Press/Media
COVID-19 test maker MicroGEM will create 100s of jobs at new Ogden plant
Thomas Moran
7/02/21
1 item of Media coverage
Press/Media
MicroGEM Establishes Ogden, Utah and Hudson, New Hampshire, Operations
Thomas Moran
3/02/21
1 item of Media coverage
Press/Media
MicroGEM Establishes Ogden, Utah and Hudson, New Hampshire, Operations
Thomas Moran
1/02/21
1 item of Media coverage
Press/Media
MicroGEM Acquires Jump Start, Expands Manufacturing To Accelerate Production Of Portable COVID-19 Saliva Test
Thomas Moran
28/01/21
1 item of Media coverage
Press/Media
MicroGEM Acquires Jump Start, Expands Manufacturing To Accelerate Production Of Portable COVID-19 Saliva Test
Thomas Moran
28/01/21
19 items of Media coverage
Press/Media
Virginia biotech firm plans to create hundreds of NH jobs at new Hudson facility
Thomas Moran
28/01/21
1 item of Media coverage
Press/Media
COVID testing company brings hundreds of manufacturing jobs to Utah
Thomas Moran
28/01/21
1 item of Media coverage
Press/Media
Icahn School of Medicine at Mount Sinai Submits Patent Application for Broadly Neutralizing Anti-Human Cytomegalovirus (HCMV) Antibodies and Methods of Use Thereof
Thomas Moran
24/10/20
1 item of Media coverage
Press/Media
Mount Sinai Gets $2.5 Million NIH Grant to Open New Avenues for Diabetes Treatment
Adolfo García-Ocaña, Dirk Homann & Thomas Moran
8/10/20
1 item of Media coverage
Press/Media
COVID-19: Are we close to a cure?
Thomas Moran
12/05/20
2 items of Media coverage
Press/Media
Living with an invisible killer, Part II
Thomas Moran
6/05/20
2 items of Media coverage
Press/Media
Living with an invisible killer
Thomas Moran
28/04/20 → 29/04/20
2 items of Media coverage
Press/Media
30 Existing Drugs Could Treat COVID-19: Study
Kris White,, Lisa Miorin, Jeffrey Johnson, Thomas Moran & Randy Albrecht,
21/04/20
1 item of Media coverage
Press/Media
Researchers use live virus to identify 30 existing drugs that could treat COVID-19
Kris White,, Lisa Miorin, Jeffrey Johnson, Thomas Moran & Randy Albrecht,
20/04/20
1 item of Media coverage
Press/Media
Researchers Use Live Virus to Identify 30 Existing Drugs that Could Treat COVID-19
Kris White,, Lisa Miorin, Jeffrey Johnson, Thomas Moran & Randy Albrecht,
20/04/20
2 items of Media coverage
Press/Media
Coming home to a health crisis; With Spanish-American War vets ill, LIers stepped up
Thomas Moran
5/04/20
1 item of Media coverage
Press/Media
Confronting a crisis: How LI united to fight an epidemic in 1898
Thomas Moran
2/04/20
1 item of Media coverage
Press/Media
Mount Sinai Joins Forces with Harbour BioMed
Thomas Moran
17/03/20
1 item of Media coverage
Press/Media
Mount Sinai, Harbour BioMed partner for cancer and COVID-19
Thomas Moran
16/03/20
2 items of Media coverage
Press/Media
Mount Sinai Partners with Harbour BioMed
Thomas Moran
14/03/20
1 item of Media coverage
Press/Media
Mount Sinai and Harbour BioMed collaborate to advance novel biotherapies to treat cancer and coronavirus COVID-19
Thomas Moran
12/03/20
1 item of Media coverage
Press/Media